SP1 and breast cancer: MiR-539 is lowly expressed in BC tissues and cell lines, and miR-539 under-expression implies poor prognosis of BC patients; miR-539 can specifically and negatively regulate specificity protein 1 to impede the growth and promote apoptosis of BC cells [16].